Concepedia

Russell Dahl

RD

Statistics

Publications

59

Citations

3.4K

H-Index

36

Active since

2004

Affiliations

Sanford Burnham Prebys Medical Discovery Institute(Current)

University of California San Diego

Rosalind Franklin University of Medicine and Science

Discovery Institute

Virginia Commonwealth University

Russell Dahl is an author at Sanford Burnham Prebys Medical Discovery Institute specializing in pharmacology, drug discovery, and medicinal chemistry.

ORCID

Publications per year

2004–2023

59

Publications

59

Small Molecular Allosteric Activator of the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) Attenuates Diabetes and Metabolic Disorders

Soojeong Kang, Russell Dahl, Wilson Hsieh et al. · Journal of Biological Chemistry · 2015 · 192 citations · Full text

, , +14

LYP inhibits T-cell activation when dissociated from CSK

Torkel Vang, Wallace H. Liu, Laurence Delacroix et al. · Nature Chemical Biology · 2012 · 138 citations

, , +12

Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor Growth

Albert G. Remacle, Vladislav S. Golubkov, Sergey A. Shiryaev et al. · Cancer Research · 2012 · 136 citations · Full text

, , +14

Small Molecules Can Selectively Inhibit Ephrin Binding to the EphA4 and EphA2 Receptors

Roberta Noberini, Mitchell Koolpe, Satyamaheshwar Peddibhotla et al. · Journal of Biological Chemistry · 2008 · 133 citations · Full text

, , +17

Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure

Changwon Kho, Ah Young Lee, Dongtak Jeong et al. · Nature Communications · 2015 · 129 citations · Full text

, , +14

1–5 of 59